DNM1L and Parkinson disease: Recombinant adeno-associated virus expressing the dominant negative Drp1 mutant or Mdivi-1, a small molecular inhibitor of Drp1, has been reported to inhibit mitochondrial fragmentation, restore dopamine release, and prevent DA neuron loss in PD animal models [172].